Cognitive enhancing drugs can improve chess play, scientists show
The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate (best known under the trade name Ritalin), and caffeine, on chess play is being published. Research shows significant cognitive improvements for modafinil and methylphenidate, and may influence how these drugs are used off-label in a range of activities. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 6, 2017 Category: Science Source Type: news
The influence of stimulants on performance when playing chess
(Johannes Gutenberg Universitaet Mainz) High-performance tournament chess players can actually enhance the highly complex cognitive functions they require by taking substances such as the CNS stimulant methylphenidate or the wakefulness promoter modafinil and thus win more chess matches -- unless they are under time pressure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2017 Category: Global & Universal Source Type: news
Scientists show cognitive-enhancing drugs can improve chess play
(European College of Neuropsychopharmacology) The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate (best known under the trade name Ritalin), and caffeine, on chess play is being published in the March edition of the peer-reviewed journal European Neuropsychopharmacology. This shows significant cognitive improvements for modafinil and methylphenidate, and may have influence how these drugs are used off-label in a range of activities. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2017 Category: Global & Universal Source Type: news
FDA gives Lannett more time to make its case for ADHD drug
The Food and Drug Administration has decided to give Lannett Co. Inc. more time to show why its generic ADHD drug should be allowed to remain in the market.
Back in October, the FDA informed the Northeast Philadelphia generic drug manufacturer that the agency was preparing to withdraw its approval of the company’s Methylphenidate Hydrochloride extended-release tablets, prescribed to treat attention deficit hyperactivity disorder, based in part on re ports by patients that the therapeutics benefits… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 22, 2017 Category: Pharmaceuticals Authors: John George Source Type: news
Drugs Vanish at Some VA Hospitals
WASHINGTON (AP) — Federal authorities are stepping up investigations at Department of Veterans Affairs medical centers due to a sharp increase in opioid theft, missing prescriptions or unauthorized drug use by VA employees since 2009, according to government data obtained by The Associated Press.
Doctors, nurses or pharmacy staff at federal hospitals — the vast majority within the VA system — siphoned away controlled substances for their own use or street sales, or drugs intended for patients simply disappeared.
Aggravating the problem is that some VA hospitals have been lax in tracking drug supplies. Co...
Source: Arkansas Business - Health Care - February 20, 2017 Category: American Health Source Type: news
Methylin Chewable Tablets (Methylphenidate HCl Chewable Tablets ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 23, 2017 Category: Drugs & Pharmacology Source Type: news
Aptensio XR (Methylphenidate Hydrochloride Extended-release Capsules ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 23, 2017 Category: Drugs & Pharmacology Source Type: news
Methylin Oral Solution (Methylphenidate HCl Oral Solution 5 mg/5 mL and 10 mg/5 mL) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 23, 2017 Category: Drugs & Pharmacology Source Type: news
Ritalin (Methylphenidate Hcl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 20, 2017 Category: Drugs & Pharmacology Source Type: news
Concerta (Methylphenidate Extended-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 20, 2017 Category: Drugs & Pharmacology Source Type: news
Mylan launches new ADHD treatment in US
US-based pharmaceuticals company Mylan has launched the Methylphenidate Hydrochloride Extended-Release Tablets USP in the country for the treatment of patients affected with attention deficit hyperactivity disorder (ADHD). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 3, 2017 Category: Pharmaceuticals Source Type: news
Mylan Launches Generic Birth Control, ADHD Pills
Mylan has announced the launch of a generic version of Actavis ' Zovia in the U.S. as well as the launch of a generic version of Janssen ' s Concerta Tablets. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 30, 2016 Category: Pharmaceuticals Source Type: news
Adderall vs. Concerta
Title: Adderall vs. ConcertaCategory: MedicationsCreated: 12/16/2016 12:00:00 AMLast Editorial Review: 12/16/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 16, 2016 Category: Drugs & Pharmacology Source Type: news
No superiority of treatment with osmotic controlled-release oral delivery system-methylphenidate over short/medium-acting methylphenidate preparations in the rate and timing of injuries in children with attention-deficit/hyperactivity disorder - Golubchik P, Kodesh A, Weizman A.
OBJECTIVES: Methylphenidate (MPH) treatment in patients with attention-deficit/hyperactivity disorder (ADHD) is reported to reduce the risk for injuries. In the present study, the rate and timing of injuries were compared among the various MPH preparations... (Source: SafetyLit)
Source: SafetyLit - December 3, 2016 Category: Global & Universal Tags: Age: Adolescents Source Type: news
ADHD Drug Plus Therapy Improves Cognitive Outcomes In TBI Patients
Study reveals combination of methylphenidate with cognitive-behavioral rehabilitation a promising option for people with persistent cognitive problems following traumatic brain injury (Source: Disabled World)
Source: Disabled World - November 25, 2016 Category: Disability Tags: Traumatic Brain Injury Source Type: news
